Olaparib and Temozolomide in Patients With SCLC: Final Analysis and CNS Outcomes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase I/II Investigator-Initiated Study of Olaparib and Temozolomide in SCLC: Final Analysis and CNS Outcomes
Clin. Cancer Res 2024 Oct 29;[EPub Ahead of Print], CB Meador, SR Digumarthy, BY Yeap, YP Hung, M Mino-Kenudson, AF Farago, RS Heist, JP Marcoux, D Rangachari, DA Barbie, Z PiotrowskaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.